Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:17 PM
Ignite Modification Date:
2025-12-24 @ 9:17 PM
NCT ID:
NCT04824404
Eligibility Criteria:
Inclusion Criteria:
* adults (≥18 years)
* having a DSM-V diagnosis of OUD
* sublingual buprenorphine/naloxone and/or buprenorphine
* having initiated maintenance treatment for OUD for at least 30 days before the screening
* self-report or toxicology screening positive for any substance within 30 days of screening;
* willing to accept a random assignment to either TAU/CBT4CBT-Buprenorphine + Recovery Coach;
* having adequate computer skills
Exclusion Criteria:
* having a severe medical or psychiatric disability that could impair their ability to perform study-related activities (determined by the clinician)
* being pregnant or breastfeeding;
* being unable to independently read and/or comprehend the consent form or other study materials
* being unable to read/speak English;
* having current suicidal ideation based on the Patient Health Questionnaire-9.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04824404
Study Brief:
Protocol Section:
NCT04824404